0001209191-15-039126.txt : 20150505
0001209191-15-039126.hdr.sgml : 20150505
20150505210025
ACCESSION NUMBER: 0001209191-15-039126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150501
FILED AS OF DATE: 20150505
DATE AS OF CHANGE: 20150505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Receptos, Inc.
CENTRAL INDEX KEY: 0001463729
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264190792
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10835 ROAD TO THE CURE
STREET 2: SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-652-5700
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE
STREET 2: SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.)
DATE OF NAME CHANGE: 20090522
FORMER COMPANY:
FORMER CONFORMED NAME: Receptor Pharmaceuticals Inc.
DATE OF NAME CHANGE: 20090507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christian Waage
CENTRAL INDEX KEY: 0001553179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35900
FILM NUMBER: 15834874
MAIL ADDRESS:
STREET 1: RECEPTOS, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-01
0
0001463729
Receptos, Inc.
RCPT
0001553179
Christian Waage
3033 SCIENCE PARK, SUITE 300
SAN DIEGO
CA
92121
0
1
0
0
SVP & General Counsel
Common Stock
2015-05-01
4
M
0
12500
22.65
A
12500
D
Common Stock
2015-05-01
4
S
0
12500
154.46
D
0
D
Employee Stock Option (right to buy)
22.65
2015-05-01
4
M
0
12500
0.00
D
2023-11-24
Common Stock
12500
112500
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.50 to $156.95 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option, representing a right to purchase a total of 150,000 shares, became exercisable as follows: 25% on the one-year anniversary of November 25, 2013 and 1/48th of the shares vest each month thereafter for the remaining three years. The option is subject to vesting acceleration in the event of certain corporate or change of control transactions.
/s/ Christian Waage
2015-05-05